Short-term low-dose pantoprazole-based triple therapy for cure of Helicobacter pylori infection in duodenal ulcer patients

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 8, 1998, Pages 731-734

  Pazzi, P ^a   Scagliarini, R ^a   Gamberini, S ^a   Matarese, V ^a   Rizzo, C ^a   Gullini, S ^a  

^a S ANNA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; LANSOPRAZOLE; PROTON PUMP INHIBITOR; TINIDAZOLE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BREATH ANALYSIS; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DUODENUM ULCER; ENDOSCOPY; FEMALE; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; STOMATITIS; TASTE DISORDER; ULCER HEALING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; ANTITRICHOMONAL AGENTS; BENZIMIDAZOLES; CLARITHROMYCIN; COMBINED MODALITY THERAPY; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; SULFOXIDES; TINIDAZOLE; TREATMENT OUTCOME;

EID: 0031822692     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00372.x     Document Type: Article

References (28)

1. Graham DY. Treatment of peptic ulcers caused by Helicobacter pylori. N Engl J Med 1993; 328: 349-50.
2. Tytgat GNJ. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359-68.
3. Hentschell E, Brandstätter G, Dragosics B, et al. Effect of ranitidine and amoxicilline plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308-12.
4. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110: 1244-52.
5. Jaspersen D, Koerner T, Schorr W, Brennensthul M, Raschka C, Hammar CH. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995; 41: 51-7.
6. Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995; 41: 1-4.
7. Labenz J, Börsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19-23.
8. Bardhan KD. Triple therapy as a cure for Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1996; 8(Suppl. 1): S27-S30.
9. Bazzoli F, Zagari RM, Fossi S, et al. Short-term low-dose therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6: 773-7.
10. Bell GD, Powell K, Burrige SM, et al. Experience with triple anti-H. pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992; 6: 427-35.
11. Noach LA, Bertola MA, Schwartz MP, Rauws EAJ, Tytgat GNJ. Treatment of H. pylori infection: an evaluation of various therapeutic trials. Eur J Gastroenterol Hepatol 1994; 6: 585-92.
12. Dalla Libera M, Pazzi P, Carli G, et al. High effectiveness and safety of one-week antibiotic regimen in Helicobacter pylori eradication. Aliment Pharmacol Ther 1996; 10: 203-6.
13. Moayyedi P, Sahay P, Tompkins S, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur Gastroenterol Hepatol 1995; 7: 835-40.
14. McGowan CC, Cover TL, Blaser MJ. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism. Gastroenterology 1994; 107: 738-43.
15. Axon ATR. The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol 1994; 29(Suppl. 201): 16-23.
16. Hartmann M, Theiss U, Huber R, et al. Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole. Aliment Pharmacol Ther 1996; 10: 359-66.
17. Hannan A, Weil J, Broom C, Walt RP. Effect of oral pantoprazole on 24-hour intragastric acidity and plasma gastrin profiles. Aliment Pharmacol Ther 1992; 6: 373-80.
18. Beker JA, Bianchi Porro G, Bigard MA, et al. Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer. Eur J Gastroenterol 1995; 7: 407-10.
19. Louw JA, Jaskiewicz K, Lucke W, et al. The proton pump inhibitors omeprazole, lansoprazole and pantoprazole have a similar effect on gastric H. pylori. Am J Gastroenterol 1994; 89: 1379 (Abstract).
20. Suerbaum S, Leying H, Klemm K, Opferkuch W. Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1991; 10: 92-3.
21. Adamek RJ, Bethke T. Pantoprazole, clarithromycin and metronidazole vs. pantoprazole and clarithromycin for cure of H. pylori infection in duodenal ulcer patients. Gastroenterology 1996; 110: A48 (Abstract).
22. Bardhan KD, Slater DN, Morton D, et al. Pantoprazole-based 10-day triple therapy is effective for H. pylori eradication. Gastroenterology 1996; 110: A57 (Abstract).
23. Labenz J, Peitz U, Tillenburg B, Becker T, Borsch G, Stolle M. Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori. Leber Magen Darm 1995; 25: 122-7.
24. Labenz J, Tillenburg B, Weismüller J, Lütke A, Stolle M. Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer. Aliment Pharmacol Ther 1997; 11: 98-100.
25. Rehner M, Rohner HG, Schepp W. Comparison of pantoprazole versus omeprazole in the treatment of acute duodenal ulceration - a multicentre study. Aliment Pharmacol Ther 1995; 9: 411-16.
26. Corinaldesi R, Valentini M, Belaiche J, Colin R, Geldof H, Maier C. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study. Aliment Pharmacol Ther 1995; 9: 667-71.
27. Mossner J, Holscher Ah Herz R, Schneider A. A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial. Aliment Pharmacol Ther 1995; 9: 321-6.
28. Fitton A, Wiseman L. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 1996; 51: 460-82.